nasdaq
Sarepta Therapeutics (NASDAQ: SRPT), a pharmaceutical company that describes itself as specializing in “precision genetic medicine for rare diseases”, saw its stock price shoot up by 36% in after-hours trading last night. But why? Ground-breaking medical breakthroughToward the end of the trading day yesterday, Sarepta announced that it had obtained approval from the U.S. Food and Drug Administration (FDA) for a treatment targeting a rare genetic disease called Duchenne muscular dystrophy (DMD). Sarepta’s DMD treatment, named ELEVIDYS (delandistrogene moxeparvovec-rokl), was given full FDA appr...
Invezz
Nasdaq-listed software firm MicroStrategy (MSTR) has expanded its substantial bitcoin (BTC) holdings, acquiring an additional 11,931 BTC for $786 million. This latest acquisition further cements MicroStrategy’s position as the largest corporate holder of bitcoin. MicroStrategy’s bitcoin accumulation strategy Led by Executive Chairman Michael Saylor, MicroStrategy began its aggressive bitcoin accumulation in 2020. As of the end of April, the company held 214,400 bitcoins. With the recent purchase, the total now stands at 226,331 bitcoins, valued at just under $15 billion, given bitcoin’s curren...
Invezz
Nasdaq Stockholm, Nasdaq Inc’s stock exchange in Sweden, has been fined 100 million Swedish kronor ($9.6 million) by the country’s financial watchdog, the Financial Supervisory Authority (Finansinspektionen), over deficiencies in monitoring insider trading violations. The regulatory body found flaws in how Nasdaq Stockholm conducted its trade monitoring during significant company events in 2021 and 2022. Deficiencies in trade monitoringThe investigation by the Financial Supervisory Authority revealed that Nasdaq Stockholm had shortcomings in its processes to prevent, identify, and report insid...
Invezz
ValueWalk
ValueWalk
ValueWalk
ValueWalk
ValueWalk
ValueWalk
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら